Viridian, Kissei Ink $70M+ Deal for Eye Drug in Japan
– Kissei obtains an exclusive license to develop and commercialize veligrotug and VRDN-003 in Japan – – Viridian to receive an upfront payment of $70...
Category : Healthcare and Pharmaceutical
Integrated Dermatology Adds NP Katie O’Brien in MA
Integrated Dermatology, the country’s largest independent dermatology provider, proudly announces that Katie O’Brien, MSN, ANP-BC, has joined its partner practice, The Dermatology Center of Worcester. A...
Henry Schein One Unveils Forms for Faster Check-In
With a native end-to-end workflow in Dentrix and Dentrix Ascend, the new Forms cuts manual work and extra logins for a smoother start to every...
NeoGenomics Launches PanTracer LBx Liquid Biopsy Test
New ctDNA-based test offers a flexible, guideline-driven solution for patients with advanced solid tumors when tissue is limited or unavailable NeoGenomics, Inc. (NASDAQ: NEO), a...
Aldevron Launches New Innovation Center in Waltham, MA
Strategic expansion places Aldevron at the heart of the Boston biotech corridor, fueling next-generation breakthroughs in genomic medicine Aldevron, a Danaher company, and a global...
IMV Reveals 2025 ServiceTrak™ Award Winners at ADLM
IMV, part of the Science and Medicine Group and the leading market research and business intelligence provider to the laboratory diagnostic industry, is pleased to...
Tsingke Biotech Hosts 2025 Nucleic Acid Therapeutics Roundtable
Industry experts gather to explore oligonucleotide innovation, delivery strategies, and commercialization pathways Tsingke Biotech, a leading provider of synthetic biology and nucleic acid solutions, successfully...
WuXi Biologics Singapore Launches Modular Drug Facility
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), announced construction has begun for a new modular Drug Product (DP) facility,...
NYU Langone Tops US with Four No.1 Medical Specialties
Once again on the Honor Roll of America’s Top 20 Hospitals, NYU Langone was evaluated alongside more than 4,500 medical centers nationally NYU Langone Health...
New Campaign Teaches What to Do When Lung Nodules Are Found
American Lung Association, in partnership with Olympus, launches educational campaign based on findings from national focus groups and patient survey In honor of World Lung...
Leo Cancer Care Gets FDA Clearance for Marie® Radiotherapy
Leo Cancer Care, a leader in upright radiotherapy solutions, today announces that its flagship product, Marie®, has received 510(k) clearance from the U.S. Food and...
Lilly’s Jaypirca Beats Imbruvica in Phase 3 CLL/SLL Trial
Pirtobrutinib met the primary endpoint of response rate non-inferiority, favoring pirtobrutinib with a nominal P-value for superiority < 0.05 Progression-free survival data was immature, but...
Kinvard Bio Gets Follow-on CARB-X Funding for New Antibiotics
Non-dilutive funding advances development of differentiated ribosome-targeting antibiotics for serious, drug-resistant infections with high unmet patient need Kinvard Bio Inc., a biotechnology company pioneering a next-generation class...
Bayer Gives Update on Elinzanetant Menopause Treatment
Bayer today announced that the U.S. Food and Drug Administration (FDA) has extended the review period for the New Drug Application (NDA) for elinzanetant. Elinzanetant...
Sarepta Issues Statement on ELEVIDYS Patient Death
Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Just before 6:00 p.m. ET today, the...